Goldman Sachs Group Inc Avita Medical, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Avita Medical, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 93,655 shares of RCEL stock, worth $499,181. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,655
Previous 167,039
43.93%
Holding current value
$499,181
Previous $1.36 Million
63.58%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RCEL
# of Institutions
87Shares Held
7.6MCall Options Held
46.5KPut Options Held
18.5K-
Black Rock Inc. New York, NY1.78MShares$9.51 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$7.73 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA618KShares$3.3 Million0.0% of portfolio
-
State Street Corp Boston, MA529KShares$2.82 Million0.0% of portfolio
-
Ubs Group Ag410KShares$2.18 Million0.0% of portfolio
About AVITA Medical, Inc.
- Ticker RCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 25,030,900
- Market Cap $133M
- Description
- AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...